Schonfeld Strategic Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.2 Billion
Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 47,282 shares of APLS stock, worth $961,243. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,282

Previous 83,916 43.66%

Holding current value

$961,243

Previous $1.45 Million 26.38%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$17.42 - $28.65 $638,164 - $1.05 Million	-36,634 Reduced 43.66%	47,282 $1.07 Million
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $1.59 Million - $2.24 Million	-97,484 Reduced 53.74%	83,916 $1.45 Million
Q1 2025 May 15, 2025	BUY	$21.87 - $34.63 $3.97 Million - $6.28 Million	181,400 New	181,400 $3.97 Million
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $222,846 - $317,966	-7,727 Reduced 24.48%	23,839 $687,000
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $1.2 Million - $1.88 Million	31,566 New	31,566 $1.21 Million

Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $3.86 Million - $14.5 Million	-163,003 Reduced 99.27%	1,200 $45,000
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $6.76 Million - $8.23 Million	88,176 Added 115.98%	164,203 $15 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $2.78 Million - $3.99 Million	59,627 Added 363.58%	76,027 $5.01 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $2.95 Million - $4.17 Million	-68,289 Reduced 80.64%	16,400 $848,000
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $582,640 - $906,764	-13,017 Reduced 13.32%	84,689 $5.78 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $3.43 Million - $5.79 Million	97,706 New	97,706 $4.42 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $4.2 Million - $6.42 Million	-118,558 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $3.3 Million - $5.27 Million	107,258 Added 949.19%	118,558 $5.61 Million
Q3 2021 Nov 16, 2021	SELL	$31.4 - $69.84 $666,747 - $1.48 Million	-21,234 Reduced 65.27%	11,300 $373,000
Q2 2021 Nov 16, 2021	SELL	$40.9 - $64.9 $204,500 - $324,500	-5,000 Reduced 13.32%	32,534 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $962,499 - $1.53 Million	23,533 Added 168.08%	37,534 $2.37 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $996,784 - $1.4 Million	-24,431 Reduced 63.57%	14,001 $601,000
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $1.18 Million - $2.2 Million	38,432 New	38,432 $2.2 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $735,509 - $1.82 Million	-41,067 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $907,580 - $1.26 Million	41,067 New	41,067 $1.26 Million
Q3 2018 Nov 14, 2018	SELL	$16.57 - $21.03 $344,175 - $436,814	-20,771 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$19.63 - $30.0 $407,734 - $623,130	20,771 New	20,771 $457,000

Others Institutions Holding APLS

# of Institutions

329

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History